Sectors

BHC
Bausch Health Companies Inc.
6.25
2900 x 6.26
6400 x 6.27
bid
ask
-
0.07
1.03%
02:11 PM
timesize
Ytd-10.00%
1y-15.70%
6.14
day range
6.36
4.33
52 week range
8.00
Open6.36Prev Close6.32Low6.14High6.36Mkt Cap2.34B
Vol829.04KAvg Vol3.52MEPS-2.94P/EN/AForward P/E1.51
Beta0.38Short Ratio1.77Inst. Own65.06%DividendN/ADiv YieldN/A
Ex Div Date11-10Earning10-2850-d Avg5.52200-d Avg5.851yr Est7.50

BHC News

Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners
prnewswire.com
Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners

This year's Aspire Higher scholarships are awarded to six students who have been affected by dermato

Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
businesswire.com
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

Can Bausch (BHC) Run Higher on Rising Earnings Estimates?
zacks.com
Can Bausch (BHC) Run Higher on Rising Earnings Estimates?

Bausch Health (BHC) shares have started gaining and might continue moving higher in the near term, a

Bausch (BHC) Upgraded to Buy: Here's What You Should Know
zacks.com
Bausch (BHC) Upgraded to Buy: Here's What You Should Know

Bausch (BHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the compa

Bausch + Lomb: The Market Is Pricing The Balance Sheet, Not The Eye-Care Engine
seekingalpha.com
Bausch + Lomb: The Market Is Pricing The Balance Sheet, Not The Eye-Care Engine

Bausch + Lomb is positioned as a turnaround and deleveraging opportunity, benefiting from a shift to

This Hedge Fund Portfolio Shrinks 17% as Billionaire Bets Big on Gold
benzinga.com
This Hedge Fund Portfolio Shrinks 17% as Billionaire Bets Big on Gold

Paulson's hedge fund reduced its equity book to $2.58B in Q2, exiting two positions and opening

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners
prnewswire.com
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners

For the Seventh Consecutive Year, 10 Students with Gastrointestinal Disease  Will Each Receive a $10

Bausch Health: Q2 Beat And Cheap, But Debt Overhang Remains Substantial
seekingalpha.com
Bausch Health: Q2 Beat And Cheap, But Debt Overhang Remains Substantial

Bausch Health Companies Inc. has surged 40% post-Q2 on strong results and raised FY2026 guidance, bu

Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term
zacks.com
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month
fool.com
Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month

Investors were cheered by the beat-and-raise second quarter. The company also had good news to repor

Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
prnewswire.com
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board

LAVAL, QC, Aug. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch

Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance
businesswire.com
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye

BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised
zacks.com
BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised

BHC beats Q2 estimates as Salix, Solta Medical and Bausch + Lomb fuel growth, lifting 2026 revenue a

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular

Bausch Health Companies Inc. (BHC) Q2 2026 Earnings Call Transcript
seekingalpha.com
Bausch Health Companies Inc. (BHC) Q2 2026 Earnings Call Transcript

Bausch Health Companies Inc. (BHC) Q2 2026 Earnings Call Transcript

Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates
zacks.com
Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates

Bausch Health (BHC) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus

Bausch Health Cos Q2 Earnings Call Highlights
marketbeat.com
Bausch Health Cos Q2 Earnings Call Highlights

Bausch Health Cos NYSE: BHC reported second-quarter results that management said extended its streak

Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say
zacks.com
Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Bausch (BHC) give a sense of how its business performed in the quar

benzinga.com
Bausch Health Companies Raises FY2026 Sales Guidance from $10.670B-$10.920B to $10.790B-$11.040B vs

Bausch Health Companies (TSX:BHC) raises FY2026 sales outlook from $10.670 billion-$10.920 billion t

benzinga.com
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.06 Estimate, Sales $2.852B Beat $2.679B Estimate

Bausch Health Companies (TSX:BHC) reported quarterly earnings of $1.26 per share which beat the anal

BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
prnewswire.com
BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE

Second Quarter Consolidated Revenues of $2.85 billion, up 13% on a Reported basis and 11% on an Orga

Bausch to stop glaucoma eye drop development after trial miss
reuters.com
Bausch to stop glaucoma eye drop development after trial miss

Bausch + Lomb said on Thursday its glaucoma eye drop had missed ​the main goal in a mid-stage ‌trial

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026
prnewswire.com
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026

LAVAL, QC, July 7, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will releas

benzinga.com
Bausch Health Announces Quebec Provincial Listing Of Prokedi For Treatment Of Schizophrenia In Adult

PrOKEDI® is a prolonged-release injectable suspension of risperidone indicated for the treatment of

Michael Goettler Resigns from Bausch Health's Board of Directors
prnewswire.com
Michael Goettler Resigns from Bausch Health's Board of Directors

LAVAL, QC, July 1, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today annou

benzinga.com
Bausch Health, Canada, Completes Negotiations With pan-Canadian Pharmaceutical Alliance Resulting In

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announce

benzinga.com
Bausch Health And Solta Medical Announce Thermage Awarded AAA Well-Known Trademark Certification By

Thermage®, a pioneer in non-invasive skin tightening, was awarded the AAA Well-Known Trademark Certi

benzinga.com
Bausch Health Companies Raises FY2026 Sales Guidance from $10.625B-$10.875B to $10.670B-$10.920B vs

Bausch Health Companies (NYSE:BHC) raises FY2026 sales outlook from $10.625 billion-$10.875 billion

benzinga.com
Bausch Health Companies Q1 Adj. EPS $0.78 Beats $0.69 Estimate, Sales $2.524B Beat $2.409B Estimate

Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $0.78 per share which beat the ana

Earnings Scheduled For April 29, 2026
benzinga.com
Earnings Scheduled For April 29, 2026

benzinga.com
RBC Capital Maintains Sector Perform on Bausch Health Companies, Lowers Price Target to $9

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perf

benzinga.com
Barclays Maintains Equal-Weight on Bausch Health Companies, Lowers Price Target to $7

Barclays analyst Glen Santangelo maintains Bausch Health Companies (NYSE:BHC) with a Equal-Weight

benzinga.com
Bausch Health Companies Sees FY2026 Sales $10.625B-$10.875B vs $10.595B Est

Bausch Health Companies (NYSE:BHC) sees FY2026 sales of $10.625 billion-$10.875 billion vs $10.595 b

Insights into Bausch Health Companies Q4 Earnings
benzinga.com
Insights into Bausch Health Companies Q4 Earnings

Bausch Health Companies Q4 Earnings Report: What Investors Need to Know
benzinga.com
Bausch Health Companies Q4 Earnings Report: What Investors Need to Know

benzinga.com
Bausch Health Companies Q4 Adj. EPS $1.10 Misses $1.26 Estimate, Sales $2.796B Beat $2.696B Estimate

Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $1.10 per share which missed the a

Earnings Scheduled For February 18, 2026
benzinga.com
Earnings Scheduled For February 18, 2026

benzinga.com
Attorney General James Secures More Than $17M from Drug Manufacturers Bausch And Lannett For Conspir

https://ag.ny.gov/press-release/2026/attorney-general-james-secures-more-17-million-drug-manufacture

benzinga.com
Bausch Health Reports Results Of Global Phase 3 RED-C Clinical Program; Trials Safe, But Did Not Mee

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced the results of the global Phase 3 

benzinga.com
Truist Securities Maintains Hold on Bausch Health Companies, Raises Price Target to $8

Truist Securities analyst Les Sulewski maintains Bausch Health Companies (NYSE:BHC) with a Hold a

Looking Into Bausch Health Companies Inc's Recent Short Interest
benzinga.com
Looking Into Bausch Health Companies Inc's Recent Short Interest

benzinga.com
Barclays Initiates Coverage On Bausch Health Companies with Equal-Weight Rating, Announces Price Tar

Barclays analyst Glen Santangelo initiates coverage on Bausch Health Companies (NYSE:BHC) with a

Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On Monday
benzinga.com
Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

benzinga.com
Bausch Health Companies And Its Global Aesthetic Business, Solta Medical, Acquired Wuhan Shibo Zhenm

The Shibo group has served as Solta Medical's trusted distribution partner over the past decade.

Carl Icahn's Biggest Bet Just Torched Half His Fortune
benzinga.com
Carl Icahn's Biggest Bet Just Torched Half His Fortune

Carl Icahn's empire, IEP, has collapsed 80% due to Hindenburg's short-selling attack. Icahn&

Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday
benzinga.com
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big

benzinga.com
Bausch Health Companies Q3 Adj. EPS $1.16 Beats $1.13 Estimate, Sales $2.681B Beat $2.637B Estimate

Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $1.16 per share which beat the ana

benzinga.com
Bausch Health Companies Raises FY2025 Sales Guidance from $10.000B-$10.250B to $10.050B-$10.250B vs

Bausch Health Companies (NYSE:BHC) raises FY2025 sales outlook from $10.000 billion-$10.250 billion

Earnings Scheduled For October 29, 2025
benzinga.com
Earnings Scheduled For October 29, 2025